annual operating expenses:
$22.06B+$1.06B(+5.06%)Summary
- As of today (August 23, 2025), NVS annual total operating expenses is $22.06 billion, with the most recent change of +$1.06 billion (+5.06%) on December 31, 2024.
- During the last 3 years, NVS annual operating expenses has fallen by -$2.09 billion (-8.67%).
- NVS annual operating expenses is now -25.26% below its all-time high of $29.52 billion, reached on December 31, 2011.
Performance
NVS Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$6.15B+$799.26M(+14.93%)Summary
- As of today (August 23, 2025), NVS quarterly total operating expenses is $6.15 billion, with the most recent change of +$799.26 million (+14.93%) on June 30, 2025.
- Over the past year, NVS quarterly operating expenses has increased by +$787.26 million (+14.67%).
- NVS quarterly operating expenses is now -26.01% below its all-time high of $8.32 billion, reached on December 31, 2011.
Performance
NVS quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
NVS Operating expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +5.1% | +14.7% |
3 y3 years | -8.7% | +6.5% |
5 y5 years | -4.0% | +6.6% |
NVS Operating expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -8.7% | +8.1% | at high | +48.9% |
5 y | 5-year | -8.7% | +8.1% | -3.6% | +48.9% |
alltime | all time | -25.3% | +123.7% | -26.0% | +667.5% |
NVS Operating expenses History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $6.15B(+14.9%) |
Mar 2025 | - | $5.36B(-10.8%) |
Dec 2024 | $22.06B(+5.1%) | $6.01B(+10.1%) |
Sep 2024 | - | $5.45B(+1.6%) |
Jun 2024 | - | $5.37B(+5.9%) |
Mar 2024 | - | $5.07B(-9.2%) |
Dec 2023 | $21.00B(+2.9%) | $5.59B(+9.7%) |
Sep 2023 | - | $5.09B(-5.6%) |
Jun 2023 | - | $5.39B(+7.6%) |
Mar 2023 | - | $5.01B(+21.2%) |
Dec 2022 | $20.41B(-15.5%) | $4.13B(-24.5%) |
Sep 2022 | - | $5.48B(-5.2%) |
Jun 2022 | - | $5.78B(+0.9%) |
Mar 2022 | - | $5.73B(-10.3%) |
Dec 2021 | $24.16B(+6.3%) | $6.38B(+9.2%) |
Sep 2021 | - | $5.85B(-2.0%) |
Jun 2021 | - | $5.97B(+6.2%) |
Mar 2021 | - | $5.62B(-10.0%) |
Dec 2020 | $22.72B(-1.1%) | $6.25B(+12.7%) |
Sep 2020 | - | $5.54B(-4.1%) |
Jun 2020 | - | $5.77B(+4.7%) |
Mar 2020 | - | $5.51B(-17.4%) |
Dec 2019 | $22.98B(+7.0%) | $6.67B(+17.6%) |
Sep 2019 | - | $5.67B(+0.8%) |
Jun 2019 | - | $5.63B(+0.2%) |
Mar 2019 | - | $5.62B(-4.3%) |
Dec 2018 | $21.48B(-5.6%) | $5.87B(+9.8%) |
Sep 2018 | - | $5.35B(-4.8%) |
Jun 2018 | - | $5.62B(+6.9%) |
Mar 2018 | - | $5.25B(-16.6%) |
Dec 2017 | $22.75B(+0.4%) | $6.29B(+11.6%) |
Sep 2017 | - | $5.64B(+0.4%) |
Jun 2017 | - | $5.62B(+4.1%) |
Mar 2017 | - | $5.39B(-12.1%) |
Dec 2016 | $22.66B(+2.6%) | $6.14B(+13.5%) |
Sep 2016 | - | $5.41B(-3.9%) |
Jun 2016 | - | $5.63B(+9.6%) |
Mar 2016 | - | $5.14B(-15.4%) |
Dec 2015 | $22.08B(-1.2%) | $6.07B(+11.8%) |
Sep 2015 | - | $5.43B(-3.3%) |
Jun 2015 | - | $5.62B(+10.0%) |
Mar 2015 | - | $5.11B(-18.6%) |
Dec 2014 | $22.36B(-4.9%) | $6.28B(+13.7%) |
Sep 2014 | - | $5.52B(-0.9%) |
Jun 2014 | - | $5.57B(-15.6%) |
Mar 2014 | - | $6.60B(+2.5%) |
Dec 2013 | $23.52B(-8.3%) | $6.44B(+12.3%) |
Sep 2013 | - | $5.74B(-2.4%) |
Jun 2013 | - | $5.88B(-8.8%) |
Mar 2013 | - | $6.45B(-17.6%) |
Dec 2012 | $25.64B | $7.82B(+19.9%) |
Sep 2012 | - | $6.52B(-3.6%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2012 | - | $6.76B(+1.3%) |
Mar 2012 | - | $6.68B(-19.7%) |
Dec 2011 | $29.52B(+11.4%) | $8.32B(+2.5%) |
Sep 2011 | - | $8.12B(-2.0%) |
Jun 2011 | - | $8.28B(+23.8%) |
Mar 2011 | - | $6.69B(-13.7%) |
Dec 2010 | $26.49B(+19.2%) | $7.75B(+36.7%) |
Sep 2010 | - | $5.67B(+8.4%) |
Jun 2010 | - | $5.23B(-0.9%) |
Mar 2010 | - | $5.28B(-21.1%) |
Dec 2009 | $22.22B(+8.6%) | $6.69B(+28.9%) |
Sep 2009 | - | $5.19B(-2.8%) |
Jun 2009 | - | $5.34B(+8.5%) |
Mar 2009 | - | $4.92B(-10.8%) |
Dec 2008 | $20.45B(+1.2%) | $5.52B(+1.3%) |
Sep 2008 | - | $5.45B(-0.0%) |
Jun 2008 | - | $5.45B(+12.0%) |
Mar 2008 | - | $4.86B(-22.3%) |
Dec 2007 | $20.20B(+15.1%) | $6.26B(+17.4%) |
Sep 2007 | - | $5.33B(+7.2%) |
Jun 2007 | - | $4.97B(+6.7%) |
Mar 2007 | - | $4.66B(-11.2%) |
Dec 2006 | $17.56B(+8.9%) | $5.25B(+16.2%) |
Sep 2006 | - | $4.52B(+2.0%) |
Jun 2006 | - | $4.43B(+13.2%) |
Mar 2006 | - | $3.91B(-5.3%) |
Dec 2005 | $16.13B(+8.3%) | $4.13B(-0.4%) |
Sep 2005 | - | $4.15B(+4.6%) |
Jun 2005 | - | $3.97B(+0.2%) |
Mar 2005 | - | $3.96B(-9.0%) |
Dec 2004 | $14.90B(+14.7%) | $4.35B(+15.3%) |
Sep 2004 | - | $3.77B(+5.3%) |
Jun 2004 | - | $3.58B(-4.9%) |
Mar 2004 | - | $3.77B(+4.8%) |
Dec 2003 | $12.99B(+19.5%) | $3.60B(+10.8%) |
Sep 2003 | - | $3.24B(-6.9%) |
Jun 2003 | - | $3.48B(+8.6%) |
Mar 2003 | - | $3.21B(+15.7%) |
Dec 2002 | $10.87B(+8.7%) | $2.77B(+0.2%) |
Sep 2002 | - | $2.77B(+4.4%) |
Jun 2002 | - | $2.65B(-344.6%) |
Mar 2002 | - | -$1.08B(-147.6%) |
Dec 2001 | $9.99B(-4.5%) | - |
Jun 2001 | - | $2.28B(+2.7%) |
Dec 2000 | $10.46B(+4.0%) | - |
Jun 2000 | - | $2.22B |
Dec 1999 | $10.06B(+2.0%) | - |
Dec 1998 | $9.86B(-1.7%) | - |
Dec 1997 | $10.03B(-21.2%) | - |
Dec 1996 | $12.72B(-1.4%) | - |
Dec 1995 | $12.91B(+7.1%) | - |
Dec 1994 | $12.06B(+1.6%) | - |
Dec 1993 | $11.87B | - |
FAQ
- What is Novartis AG annual total operating expenses?
- What is the all time high annual operating expenses for Novartis AG?
- What is Novartis AG annual operating expenses year-on-year change?
- What is Novartis AG quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Novartis AG?
- What is Novartis AG quarterly operating expenses year-on-year change?
What is Novartis AG annual total operating expenses?
The current annual operating expenses of NVS is $22.06B
What is the all time high annual operating expenses for Novartis AG?
Novartis AG all-time high annual total operating expenses is $29.52B
What is Novartis AG annual operating expenses year-on-year change?
Over the past year, NVS annual total operating expenses has changed by +$1.06B (+5.06%)
What is Novartis AG quarterly total operating expenses?
The current quarterly operating expenses of NVS is $6.15B
What is the all time high quarterly operating expenses for Novartis AG?
Novartis AG all-time high quarterly total operating expenses is $8.32B
What is Novartis AG quarterly operating expenses year-on-year change?
Over the past year, NVS quarterly total operating expenses has changed by +$787.26M (+14.67%)